CATHERINE UDOFIA: Open Payments
NPI 1023411766 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$300 in 9 payments from 4 companies in 2025. Trend: 2023 $1,372 · 2024 $502 · 2025 $300
Food & beverage: $300
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $195 |
| Janssen Pharmaceuticals, Inc | 2 | $55 |
| ACADIA Pharmaceuticals Inc | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: LYBALVI, ARISTADA, INVEGA, NUPLAZID, COBENFY.
Industry payments across LA — which companies pay providers there.
